Business
Why this top broker expects CSL shares to surge 26%
Image source: Getty Images
CSL Ltd (ASX: CSL) shares look well-placed to shake-off the past year’s decline and charge higher into 2026.
That’s according to Morgans Financial, which labelled the S&P/ASX 200 Index (ASX: XJO) biotech stock “materially undervalued”.
CSL shares closed down 0.62% on…
Continue Reading